Thyrocare: Promoter Docon Releases Pledge on 1.75 Cr Shares

Thyrocare Technologies Ltd announced that its promoter, Docon Technologies Private Limited, has released a pledge on 1,75,00,000 equity shares. The pledge was released by Catalyst Trusteeship Limited, acting as Debenture Trustee, on August 11, 2026. This release pertains to security for Non-Convertible Debentures issued by API Holdings Limited, Docon's holding company. Docon previously held 60.92% of Thyrocare's equity, with a significant portion encumbered. The disclosure was made pursuant to SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.